Literature DB >> 17600329

A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior.

Xia Li1, Jianlin Shi, Xiaoping Dong, Lingxia Zhang, Hongyu Zeng.   

Abstract

Composite scaffolds of mesoporous bioactive glass (MBG)/polycaprolactone (PCL) and conventional bioactive glass (BG)/PCL were fabricated by a solvent casting-particulate leaching method, and the structure and properties of the composite scaffolds were characterized. The measurements of the water contact angles suggest that the incorporation of either MBG or BG into PCL can improve the hydrophilicity of the composites, and the former is more effective than the later. The bioactivity of the composite scaffold is evaluated by soaking the scaffolds in a simulated body fluid (SBF) and the results show that the MBG/PCL composite scaffolds can induce a dense and continuous layer of apatite after soaking in SBF for 3 weeks, as compared with the scattered and discrete apatite particles on the BG/PCL composite scaffolds. Such improvements (improvements of the hydrophilicity and apatite forming ability) should be helpful for the extensive applications of PCL scaffold in tissue engineering. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17600329     DOI: 10.1002/jbm.a.31371

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  21 in total

Review 1.  Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review.

Authors:  Jasmin Hum; Aldo R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2012-02-24       Impact factor: 3.896

2.  Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application.

Authors:  Chengtie Wu; Jiang Chang
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

3.  Preparation and characterization of mesoporous bioactive glass/polycaprolactone nanofibrous matrix for bone tissues engineering.

Authors:  Hsiu-Mei Lin; Yi-Hsuan Lin; Fu-Yin Hsu
Journal:  J Mater Sci Mater Med       Date:  2012-08-09       Impact factor: 3.896

Review 4.  Recent advances and future perspectives of sol-gel derived porous bioactive glasses: a review.

Authors:  Kalim Deshmukh; Tomáš Kovářík; Tomáš Křenek; Denitsa Docheva; Theresia Stich; Josef Pola
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 4.036

Review 5.  Drug delivery using composite scaffolds in the context of bone tissue engineering.

Authors:  Cecilia Romagnoli; Federica D'Asta; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

6.  Composite scaffolds of mesoporous bioactive glass and polyamide for bone repair.

Authors:  Jiacan Su; Liehu Cao; Baoqing Yu; Shaojun Song; Xinwei Liu; Zhiwei Wang; Ming Li
Journal:  Int J Nanomedicine       Date:  2012-05-21

7.  In vivo experimental study on bone regeneration in critical bone defects using PIB nanogels/boron-containing mesoporous bioactive glass composite scaffold.

Authors:  Xiaohui Chen; Yanbing Zhao; Shinan Geng; Richard J Miron; Qiao Zhang; Chengtie Wu; Yufeng Zhang
Journal:  Int J Nanomedicine       Date:  2015-01-22

8.  Mesoporous magnesium silicate-incorporated poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) bioactive composite beneficial to osteoblast behaviors.

Authors:  Yunfei Niu; Wei Dong; Han Guo; Yuhu Deng; Lieping Guo; Xiaofei An; Dawei He; Jie Wei; Ming Li
Journal:  Int J Nanomedicine       Date:  2014-05-27

9.  Periodontal regeneration using strontium-loaded mesoporous bioactive glass scaffolds in osteoporotic rats.

Authors:  Yufeng Zhang; Lingfei Wei; Chengtie Wu; Richard J Miron
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

10.  High calcium bioglass enhances differentiation and survival of endothelial progenitor cells, inducing early vascularization in critical size bone defects.

Authors:  Karam Eldesoqi; Caroline Seebach; Christina Nguyen Ngoc; Simon Meier; Christoph Nau; Alexander Schaible; Ingo Marzi; Dirk Henrich
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.